Biotech Values

[DewDiligence]

DNDN and Nadine:

I was not exactly overjoyed to see a DNDN endorsement from Nadine Wong. I’ve followed Nadine’s writings with vicarious interest as she has bumped along from one venue to another during the past five years, and I’ve long thought her commentaries were the most vacuous of anyone writing professionally about biotech.

Back in mid-2000, Nadine was writing for a now-defunct website called worldlyinvestor.com. By sheer coincidence, I was renting a condominium from one of the founders of worldlyinvestor and, in reply to an offhand query from the boss, I singled out Nadine as the kind of writer I’d most like to not read.

It probably had nothing to do with my remark, but a short time later Nadine was gone from worldlyinvestor and resurfaced at TheStreet.com. Well, evidently, TSC concluded that Nadine was no Adam Feuerstein (remember him?) because I recall only one of two articles from her under TSC’s byline.

Anyhow, if Nadine has turned bullish on DNDN, that can’t be a good thing. Color me long, but slightly more concerned.